- $9.43bn
- $8.88bn
- $642.82m
U.S. STOCKS ON THE MOVE-Ultragenyx Pharma, Winnebago, Par Pacific
Impact of NIH job cuts "better than feared" for life sciences firms, Leerink says
Brief: 10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
10x Genomics falls on disappointing 2025 sales forecast
U.S. RESEARCH ROUNDUP-Applovin, Equinix, Hubspot
10X Genomics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: 10X Genomics Q4 Operating Income USD -49.8 Million Vs. IBES Estimate USD -40.5 Million
U.S. STOCKS ON THE MOVE-Nike, WesBanco, Monday.Com
U.S. STOCKS ON THE MOVE-NXP Semiconductors, Oil stocks, Mobileye
10x Genomics, Quanterix worst-hit if US health agency cuts costs, Leerink says
10x, Harvard settle genomics patent dispute with Vizgen during trial (updated)
10x, Harvard settle genomics patent dispute with Vizgen during trial
U.S. RESEARCH ROUNDUP- Alphabet, Arthur J. Gallagher & Co, Leggett & Platt
10X Genomics Inc reports results for the quarter ended in January 1 - Earnings Summary
Brief: 10X Genomics Q3 Gross Margin 70%
10X Genomics falls on weak preliminary Q3 revenue
U.S. RESEARCH ROUNDUP-Abbott, Gilead, Roku
10X Genomics Inc reports results for the quarter ended in June - Earnings Summary
Brief: 10X Genomics Q2 Revenue USD 153.1 Million Vs. IBES Estimate USD 150.1 Million